Martin Caha
Allergy & Immunology · San Diego, CANPI 1720548209
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,644 of the $7,462 with a category attached, or 75.6%. 29 manufacturers reported payments, led by Sanofi at 28.2% of the total.
Across 136 payments — averaging $54.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$2K
- Regeneron$1K
- Biocryst US Sales Co., LLC$486
- GSK$472
- Dermavant Sciences, Inc.$450
- Regeneron Healthcare Solutions, Inc.$314
- plus $3K from 23 others
Across 5 payments — averaging $10,636 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$52K
- Regeneron$1K
What the payments were for
- Grants$1,80024%
- Food & beverage$5,64476%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 22 | $2,106 |
| Regeneron | 1 | $1,000 |
| Biocryst US Sales Co., LLC | 10 | $486 |
| GSK | 17 | $472 |
| Dermavant Sciences, Inc. | 4 | $450 |
| Regeneron Healthcare Solutions, Inc. | 4 | $314 |
| ARS Pharmaceuticals Operations, Inc. | 12 | $262 |
| Pharming Healthcare, Inc. | 4 | $187 |
| Blueprint Medicines Corporation | 3 | $186 |
| Alk-abello, Inc | 3 | $183 |
| AstraZeneca | 4 | $183 |
| CSL Behring | 8 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $165 |
| Sanofi-aventis U.S. LLC | 1 | $148 |
| Amgen(2 entities) | 4 | $139 |
| Grifols USA, LLC | 6 | $125 |
| SK Life Science, Inc. | 1 | $125 |
| Alkermes, Inc. | 1 | $117 |
| Sanofi US Services Inc. | 1 | $117 |
| Incyte Corporation | 3 | $105 |
| Novartis | 4 | $96 |
| Arcutis Biotherapeutics, Inc. | 3 | $62 |
| Ionis Pharmaceuticals, Inc. | 2 | $58 |
| Lilly USA, LLC | 2 | $47 |
| Insmed, Inc. | 2 | $40 |
| GC Biopharma USA, Inc. | 2 | $38 |
| Azurity Pharmaceuticals, Inc. | 2 | $36 |
| Greer Laboratories, Inc. | 1 | $23 |
| Pfizer | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,462 in reported general payments places this provider in the 70th percentile of 426 allergy & immunology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 48 | $563 |
| Fluticasone Propionate | 67 | $504 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $371 |
| Montelukast Sodium | 23 | $245 |
| Prednisone | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in San Diego
- Bob GengSan Diego$3.3M
- Andrew WhiteSan Diego$752K
- Marc RiedlSan Diego$725K
- Katharine WoessnerSan Diego$581K
- Bruce ZurawSan Diego$232K
- Brian StoneSan Diego$146K
- Bruce PrennerSan Diego$129K
- Seema AcevesSan Diego$122K
- Susan LaubachSan Diego$86K
- Harold HoffmanSan Diego$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.